Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$3.65M
10K shares
What this filing means
BATE KENNETH plans to sell 10K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $3.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/15/2025ACC: 0001950047-25-005932
Director
Since Jun 2019
10K
Shares to sell
$3.65M
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
8/15/2025
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2025 | Exercise of options under a registered plan Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$3.65M
8/15/2025
Total
Units
10K
Value
$3.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/15/2025 | 10K | $3.65M | NASDAQ | Planned |
| Total | 10K | $3.65M | ||